|
首頁 > 美迪醫訊 > Chinese Acarbose market report |
Chinese Acarbose market report 【?2008-07-11 發布?】 美迪醫訊
Chinese Acarbose market reportResearch report of Chinese Acarbose market(API and Preparation)
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:
Format: Hardcopy and Adobe PDF
Price: US$2,100
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Brief introduction
Acarbose is a pseudo-tetrasaccharide produced by biosynthesis, the first drug in the class called alpha-glucosidase inhibitors, aslo the first alpha-glucosidase inhibitor approved by US FDA, developed by Bayer AG。Acarbose was marketed in Germany firstly in July 1984, brand name Glucobay. Acarbose is the top 1 seller in the oral antidiabetic market in China.
The report (2006 edition) represents the import and export status of Acarbose API, production status of Acarbose API in China, sales analysis of Acarbose preparations in China, and the suggestions for marketing. In the report you can know the global output and market size of Acarbose API, market sizes of Acarbose API and preparations in China, the prices, the key manufacturers.
The table of contents
Overview of Acarbose market in China and the global marekt
1 Manufacturers of Acarbose API(Bulk drug)
1.1 Bayer AG
1.2 Chinese enterprises
1.2.1 Sichuan Industrial Institute of Antibiotics Co. Ltd. (SIIA Co.Ltd.)
1.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
1.2.3 Zhejiang Zhebei Pharmaceutical Co.,Ltd.
1.2.4 Zhejiang Hisun Pharmaceutical CO., Ltd
2 Import and export situation of Acarbose API
2.1 Export statistic
2.2 Import statistic
3 Sales analysis of Acarbose preparations in sample hospitals
3.1 Market scale and market shares of different drugs in Chinese market of drugs for regulating blood sugar
3.2 Market shares and growth trend of Acarbose preparations of different enterprises from 2002 to 2005
3.2.1 Bayer AG
3.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
3.2.3 Sichuan Baoguang Pharmaceutical Technology Co., LTD
3.3 Sales analysis in sample cities
3.4 Analysis of other competition breeds
3.4.1 Voglibose
3.4.2 Repaglinide
4 Suggestions for marketing
本文關鍵字:
《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢
《上海醫療器械批發》產品推薦
|
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303 美迪醫療網業務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |